Orbital fat as an imaging biomarker of nutritional status and systemic inflammation in patients with non-small cell lung cancer
Abstract
Orbital fat has recently attracted attention as a unique adipose tissue compartment with potential metabolic and inflammatory significance. However, its relationship with nutritional status and systemic inflammation in patients with non-small cell lung cancer (NSCLC) remains poorly understood. This study aimed to evaluate orbital fat volume and radiological density on computed tomo g raphy (CT) and to investigate their associations with body mass index (BMI) and systemic inflammatory markers in patients with NSCLC. A retrospective study included 86 patients with histologically confirmed NSCLC. Orbital fat was semiautomatically se g mented on CT images using the 3D Slicer software. Total orbital fat volume and mean radiological density expressed in Hounsfield units (HU) were calculated for each patient. Clinical data and complete blood - count-derived inflammatory markers, including neutr o phil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII), were collected from medical records. Associations between orbital fat parameters and clinicopathological characteristics were assessed using Pea r son’s chi-square test, Spearman’s correlation analysis, and multivariable linear regression models. The mean orbital fat volume was 9.7 ± 1.4 cm³, while the mean radiological density was 77.0 ± 6.9 HU. Patients with larger orbital fat volume demonstrated signif i cantly higher BMI and lower levels of NLR, PLR, and SII. Orbital fat volume showed a positive correlation with BMI (ρ = 0.561, P < 0.001) and negative correlations with NLR (ρ = −0.242, P = 0.025), PLR (ρ = −0.361, P < 0.001), and SII (ρ = −0.335, P = 0.002). Radiological density was positively associated with BMI (ρ = 0.689, P < 0.001) and inversely correlated with PLR (ρ = −0.412, P < 0.001) and SII (ρ = −0.220, P = 0.042). In multivariable analyses adjusted for BMI, the associations between orbital fat volume and inflammatory markers lost statistical significance. By contrast, radiological density remained independently associated with PLR (β = −0.013, P = 0.007). These findings suggest that orbital fat volume primarily reflects nutritional status in patients with NSCLC, wher e as radiological density may provide additional information regarding systemic inflammation. Quantitative CT assessment of orbital fat represents a promising noninvasive imaging biomarker of metabolic and inflammatory alterations in this patient population.References
Alkhadrawi, A. M., Lin, L. Y., Langarica, S. A., Kim, K., Ha, S. K., Lee, N. G., & Do, S. (2024). Deep-learning based automated segmentation and quantitative volumetric analysis of orbital muscle and fat for diagnosis of thyroid eye disease. Investigative Ophthalmology and Visual Science, 65(5), 6.
Al-Sawaf, O., Weiss, J., Skrzypski, M., Lam, J. M., Karasaki, T., Zambrana, F., Kidd, A. C., Frankell, A. M., Watkins, T. B. K., Martínez-Ruiz, C., Puttick, C., Black, J. R. M., Huebner, A., Bakir, M. A., Sokač, M., Collins, S., Veeriah, S., Magno, N., Naceur-Lombardelli, C., & Swanton, C. (2023). Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29(4), 846–858.
Cheng, Y., Zhang, K., Liu, J., & Liu, G. (2025). Orbital fat is an observation model to provide insights into adipocyte hypertrophy and hyperplasia during white adipose tissue expansion. Diabetes, Metabolic Syndrome and Obesity, 18, 2977–2984.
Dadson, P., Ngum, P., Juarez-Orozco, L. E., Ntodie, M., & Loba, P. (2025). The relevance and potential role of orbital fat in inflammatory orbital diseases: Implications for diagnosis and treatment. Ophthalmology and Therapy, 14(2), 247–281.
Erkoç, M. F., Öztoprak, B., Gümüş, C., & Okur, A. (2015). Exploration of orbital and orbital soft-tissue volume changes with gender and body parameters using magnetic resonance imaging. Experimental and Therapeutic Medicine, 9(5), 1991–1997.
Fisk, H. L., Childs, C. E., Miles, E. A., Ayres, R., Noakes, P. S., Paras-Chavez, C., Antoun, E., Lillycrop, K. A., & Calder, P. C. (2022). Dysregulation of subcutaneous white adipose tissue inflammatory environment modelling in non-insulin resistant obesity and responses to omega-3 fatty acids: A double blind, randomised clinical trial. Frontiers in Immunology, 13, 922654.
González-Gil, E. M., Peruchet-Noray, L., Sedlmeier, A. M., Christakoudi, S., Biessy, C., Navionis, A. S., Mahamat-Saleh, Y., Jaafar, R. F., Baurecht, H., Guevara, M., Etxezarreta, P. A., Verschuren, W. M. M., Boer, J. M. A., Olsen, A., Tjønneland, A., Simeon, V., Castro-Espin, C., Aune, D., Heath, A. K., & Dossus, L. (2024). Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank. BMC Medicine, 22(1), 334.
Huang, J. X., Zhang, X., Yang, M., Tang, M., Zhang, Q., Deng, L., Song, C. H., Li, W., Shi, H. P., & Cong, M. H. (2026). Body mass index-based inflammation index is a promising prognostic predictor in older adult cancer patients. BMC Geriatrics, 26(1), 442.
Huang, W., Han, X., Zhang, G., & Liu, X. (2025). Radiomics-based identification of benign and malignant orbital lesions using contrast-enhanced CT imaging. Medicine, 104(45), e45791.
Jo, H., Yoshida, T., Horinouchi, H., Yagishita, S., Matsumoto, Y., Shinno, Y., Okuma, Y., Goto, Y., Yamamoto, N., Takahashi, K., Motoi, N., & Ohe, Y. (2022). Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab. Cancer Immunology, Immunotherapy, 71(2), 387–398.
Kim, D. W., Taneja, K., Hoang, T., Santiago, C. P., McCulley, T. J., Merbs, S. L., Mahoney, N. R., Blackshaw, S., & Rajaii, F. (2021). Transcriptomic profiling of control and thyroid-associated orbitopathy (TAO) orbital fat and TAO orbital fibroblasts undergoing adipogenesis. Investigative Ophthalmology and Visual Science, 62(9), 24.
Kuo, P. C., Kuo, S. C., Teng, Y. S., & Lai, C. C. (2025). Association of obesity with orbital fat expansion in thyroid eye disease. BMC Ophthalmology, 25, 2.
Landau Prat, D., Nissan, E., Shcolnik, E., Weissman, A., Rosenfeld, A., Arazi, M., Greenberg, G., & Ben Simon, G. J. (2024). Orbital fat density as a diagnostic tool in pre-septal and orbital cellulitis. Seminars in Ophthalmology, 39(3), 223–228.
Li, Z., Chen, K., Yang, J., Pan, L., Wang, Z., Yang, P., Wu, S., & Li, J. (2022). Deep learning-based CT radiomics for feature representation and analysis of aging characteristics of Asian bony orbit. Journal of Craniofacial Surgery, 33(1), 312–318.
Ma, M., Luo, M., Liu, Q., Zhong, D., Liu, Y., & Zhang, K. (2024). Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: A retrospective cohort study. Journal of Cancer Research and Clinical Oncology, 150(3), 111.
Moskalenko, Y., Kovchun, V., Bohdanov, A., Budko, V., & Yazykov, O. (2025). Visceral adipose tissue radiodensity as a potential biomarker of immunotherapy efficacy in metastatic non-small cell lung cancer patients. Galician Medical Journal, 32(3), e-GMJ2025-A21.
Peng, J., Xiang, J., Hu, J., Chen, Z., & Wu, F. (2025). Nutritional-inflammatory balance assessed by advanced lung cancer inflammation index and its association with all-cause mortality in coronary heart disease: A retrospective cohort study. Journal of Health, Population and Nutrition, 44(1), 317.
Sankar, K., Kazemian, E., Lorona, N., Cruz-Hernández, C. D., Bryant, A. K., Mastali, M., Merchant, A. A., Van Eyk, J., Reckamp, K. L., Iyengar, P., Bhowmick, N. A., & Figueiredo, J. C. (2026). Circulating inflammatory and mitochondrial biomarkers associated with cachexia in advanced non-small cell lung cancer. Cancers, 18(4), 655.
Solmaz, I. A., & Ertan, E. (2025). Association of body mass index with orbital fat volume in lower eyelid blepharoplasty. BMC Ophthalmology, 25(1), 505.
Vagnildhaug, O. M., Habberstad, R. H., Salvesen, Ø., Balstad, T. R., Bye, A., Dajani, O., Kaasa, S., Klepstad, P., & Solheim, T. S. (2025). A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: A prospective observational study. Journal of Circulating Biomarkers, 14, 12–20.
Wang, X., Liang, X., Jiang, M., Wei, L., Shi, X., Fang, F., & Cang, J. (2025). Systemic inflammation as a mediator in the link between obesity and depression: Evidence from a nationwide cohort study. BMC Psychiatry, 25(1), 449.
Xiong, C., Ren, Z., Li, X., Jin, Q., Wang, S., Gan, P., Wang, Y., & Liao, H. (2024). Orbital computed tomography imaging characteristics of thyroid-associated ophthalmopathy. Scientific Reports, 14, 28960.
Zhang, H., Jiang, M., Chan, H. C., Zhang, H., Xu, J., Liu, Y., Zhu, L., Tao, X., Xia, D., Zhou, L., Li, Y., Sun, J., Song, X., Zhou, H., & Fan, X. (2024). Whole-orbit radiomics: Machine learning-based multi- and fused-region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease. Journal of Translational Medicine, 22(1), 56.
Zhang, J., Wang, Y., Liu, H., Lei, Z., Cheng, S., & Cao, H. (2025). The association between eight complete blood count-derived inflammatory markers and muscle health. Frontiers in Nutrition, 12, 1498757.
Zhang, K., Zhou, Y., Xie, Z., & Liu, G. (2023). Subcutaneous and orbital adipose tissues: Intrinsic differences in carotenoid contents and lipidomic compositions. ACS Omega, 8(31), 28052–28059.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
